Melanoma

 Print this Page

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use available at www.bccancer.bc.ca/legal.htm .

PLEASE NOTE: All links in the table below open PDF documents.

PROTOCOL CODE and DESCRIPTION	AVAILABLE DOCUMENTS (revision date indicated in red)
SMAJIFN: Adjuvant Therapy of High Risk Malignant Melanoma with High Dose Interferon (HDIFN) -2b.	- Protocol (01 Oct 2009)  - Preprinted order (01 May 2009)  - Patient Handout (01 Oct 2009)
SMCCNU: Second line treatment for metastatic malignant melanoma using Lomustine (CCNU).	- Protocol (01 May 2009)  - Preprinted order (01 May 2009)
SMDTIC: Therapy for metastatic malignant melanoma using high dose single agent Dacarbazine (DTIC).	- Protocol (01 May 2009)   - Preprinted order (01 May 2009)
SMILBCG: Therapy for local or regional metastatic malignant melanoma using Intralesional BCG.	- Protocol (01 May 2009)
SMTAM: Therapy for malignant melanoma using Tamoxifen	- Protocol (01 May 2009)